Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Cash from Discontinued Operations (2016 - 2017)

Protalix BioTherapeutics has reported Cash from Discontinued Operations over the past 3 years, most recently at 2000.0 for Q3 2017.

  • Quarterly results put Cash from Discontinued Operations at 2000.0 for Q3 2017, up 100.68% from a year ago — trailing twelve months through Sep 2017 was 116000.0 (down 97.19% YoY), and the annual figure for FY2016 was 11000.0, down 100.74%.
  • Cash from Discontinued Operations for Q3 2017 was 2000.0 at Protalix BioTherapeutics, up from 8000.0 in the prior quarter.
  • Over the last five years, Cash from Discontinued Operations for PLX hit a ceiling of 4138000.0 in Q4 2015 and a floor of 1406000.0 in Q3 2015.
  • Median Cash from Discontinued Operations over the past 3 years was 131000.0 (2015), compared with a mean of 159100.0.
  • Biggest five-year swings in Cash from Discontinued Operations: skyrocketed 164.72% in 2016 and later crashed 101.25% in 2017.
  • Protalix BioTherapeutics' Cash from Discontinued Operations stood at 4138000.0 in 2015, then tumbled by 107.15% to 296000.0 in 2016, then skyrocketed by 100.68% to 2000.0 in 2017.
  • The last three reported values for Cash from Discontinued Operations were 2000.0 (Q3 2017), 8000.0 (Q2 2017), and 122000.0 (Q1 2017) per Business Quant data.